TULSA, Okla., Sept. 26, 2011 (GLOBE NEWSWIRE) -- 3DIcon Corporation (OTCBB:TDCP), a developer of volumetric, three-dimensional projection and display technologies, today announced it has retained the services of China-based Yongsen Consulting as its exclusive advisor in China. The firm is led by Dr. Fei Li, a business executive with expertise in technology and collaboration between American and Chinese companies.
Yongsen Consulting's primary focus will be to provide capital raising efforts for 3DIcon with China based investors. As 3DIcon seeks to expand its business and technology development and commercialization efforts, Yongsen Consulting and Dr. Li's services will also include identifying and negotiating with Chinese firms for potential joint ventures, collaborations, and strategic alliances, as well as possible acquisitions if appropriate.
"There is a significant opportunity we will pursue through business development in China. I have worked closely with Dr. Li for a number of years and have a great deal of personal confidence in her abilities both in technology and business matters. We feel she will effectively pursue our interests in the complex environment that China represents," stated Sidney Aroesty, Chief Executive Officer of 3DIcon.
Dr. Fei Li is well known in the Chinese and U.S. life science industries for her vision, strategic thinking and exceptional execution ability in transforming emerging technologies into marketable products leading to revenue generation. Dr. Li started her career by obtaining her M.D. degree from Sun Yat-sen University of Medical Sciences, one of the top medical schools in China in 1994. After working as an internal medicine doctor in a Chinese hospital, she came to United States to further her education and obtained a Ph.D. degree in Biomedical Sciences from the University of California, Riverside and a Masters degree in Business Administration from the University of Redlands. In 2001, Dr. Li joined Diagnostic Product Corporation ("DPC") and held various positions at DPC with increasing responsibilities, including Senior Scientist, R&D manager, and Validation Director. Dr. Li returned to China in 2007 after Siemens acquired DPC, leading and managing all strategic planning and business development efforts for Siemens' clinical diagnostic business, contributing significantly to the company's impressive growth in the Chinese market. Dr. Li subsequently joined Beyond Diagnostic, a high-tech medical device company based in Shanghai, as Chief Operating Officer. Under her leadership, the company obtained regulatory approval for 14 products and transformed from a research lab into a market-driven, customer oriented, and fast growing medical device manufacturer.
About 3DIcon Corporation
3DIcon Corporation is a developer of groundbreaking 3D projection and display technologies that are designed to produce full color, high-resolution, 360-degree volumetric images, a development many consider to be the next step in 3D display technology. CSpace creates both dense and translucent images for use in mission critical functions including healthcare, security and defense. CSpace enables viewing inside organs, cargo containers, and baggage, as well as large scale terrain such as oceans and mountains, all of which are beyond the capabilities of other current display methodologies. The company also offers a software product, Pixel Precision®, which targets the R&D market for developers using Texas Instruments' DLP® line of products. For visualization of CSpace images please visit www.3dicon.net.
The 3DIcon Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7750
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION ACT OF 1995
With the exception of historical information, the matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties. The actual future results of 3DIcon could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company's operations, inability to hire and retain qualified personnel, and changes in the general economic climate. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by 3DIcon, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements.